Mitsubishi, Janssen Seek To Block Generic Diabetes Drug
By Jasmin Boyce ( March 23, 2020, 5:21 PM EDT) -- Mitsubishi Tanabe Pharma and the licensees of its diabetes drug Invokamet XR have hit generic-drug manufacturer Aurobindo Pharma USA with a patent infringement suit in New Jersey federal court over what they allege to be a hasty attempt to sell generic versions of the medication....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.